|
OFT_distance total distance traveled, 20 min test
54801
|
Female |
47 |
Male |
50 |
|
OFT_center time spent in center, 20 min test
54802
|
Female |
47 |
Male |
50 |
|
novel_wall percentage of total time spent in chamber with novel wall, 10 min test
54811
|
Female |
46 |
Male |
49 |
|
hole_pokes number of hole pokes, 10 min test
54821
|
Female |
44 |
Male |
48 |
|
FR1_infusions_mean intravenous self-administration, mean number of infusions (fixed ratio 1 (FR1) schedule), over ten 120 min sessions
54831
|
Female |
32 |
Male |
38 |
|
FR1_active_mean intravenous self-administration, mean number of responses on the active lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions
54832
|
Female |
32 |
Male |
38 |
|
FR1_inactive_mean intravenous self-administration, mean number of responses on the inactive lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions
54833
|
Female |
32 |
Male |
38 |
|
PR_infusions_breakpoint intravenous self-administration, breakpoint for infusions (progressive ratio (PR) schedule), one 6h test
54841
|
Female |
32 |
Male |
30 |
|
PR_active intravenous self-administration, number of presses on the active lever (progressive ratio (PR) schedule), one 6h test
54842
|
Female |
32 |
Male |
30 |
|
PR_inactive intravenous self-administration, number of presses on the inactive lever (progressive ratio (PR) schedule), one 6h test
54843
|
Female |
32 |
Male |
30 |
|